Egyptian Exchange to list EGX 30 index futures on NYSE Liffe London
- Egypt: Tuesday, January 15 - 2013 at 06:23
The Egyptian Exchange (EGX) has signed a license agreement with NYSE Liffe, the European derivatives business of NYSE Euronext, to list the EGX 30 index. The agreement will enable NYSE Liffe to work with market participants to develop and launch a futures contract based on the EGX 30 index. "Futures contract on EGX 30 index will increase volumes on the underlying constituents of EGX 30 index, which will increase liquidity on EGX cash market," said EGP chairman, Dr Mohamed Omran. "Furthermore, it will introduce for the first time a beneficial hedging tool for investors to manage their risks."
- Saudia to stop Jeddah-Kano service
- Oman Air first GCC carrier to order B737-900ER...
- Iran cancels local drilling rigs deal, to buy...
- Gamification hits the Middle East
- Sammy Tuffaha underscores importance of...
- Forum International introduces www....
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AMEinfo.com Web site does not constitute advice or a recommendation by Mediaquest FZ LLC and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AMEinfo.com Web site.
Mediaquest FZ LLC can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AMEinfo.com Web site nor do opinions of contributors necessarily reflect those of Mediaquest FZ LLC.
In no event shall Mediaquest FZ LLC be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AMEinfo.com Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.